The Life Science industry and regulatory profession have a plethora of acronyms and technical terms. Our glossary aims to help make sense of these. Search by clicking on the letters above.
Latest definitions
glossary
Environment Scanning
Identification of the stakeholders which are likely to use, benefit or assess the health tech product in development and which…
glossary
End of Trial (EoT) Declaration
Clinical trial sponsors are required to notify regulatory authorities and ethics committees when their clinical trials have ended. End of…
glossary
EMA HTA Parallel Scientific Advice
When developing a medicinal product, two milestones are of importance for making its path to the market: the granting of…
glossary
Efficacy-Effectiveness Gap
The observed discrepancy between effects of a health intervention in routine clinical practice as compared with the effects demonstrated in…
glossary
Efficacy
The measurement of a medicine’s desired effect as compared to another healthcare intervention under ideal conditions, such as in a…
glossary
Effectiveness
The achievement of desired results under the usual circumstances of health care practice.
glossary
Early Dialogues Working Party (EDWP)
The Early Dialogues Working Party (EDWP) is a standing committee established by EUnetHTA to ensure robust high-quality HTA outputs. All…
glossary
De Novo
The US Food and Drug Administration (FDA) automatically classifies Class I or II medical devices without a predicate as class…
Resources 